Michael Jeltsch

16.0k total citations · 7 hit papers
73 papers, 12.3k citations indexed

About

Michael Jeltsch is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Michael Jeltsch has authored 73 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 51 papers in Oncology and 16 papers in Surgery. Recurrent topics in Michael Jeltsch's work include Lymphatic System and Diseases (50 papers), Angiogenesis and VEGF in Cancer (48 papers) and Vascular Malformations and Hemangiomas (10 papers). Michael Jeltsch is often cited by papers focused on Lymphatic System and Diseases (50 papers), Angiogenesis and VEGF in Cancer (48 papers) and Vascular Malformations and Hemangiomas (10 papers). Michael Jeltsch collaborates with scholars based in Finland, United States and Sweden. Michael Jeltsch's co-authors include Kari Alitalo, Christer Betsholtz, Vladimir Joukov, Marc G. Achen, Steven A. Stacker, Eola Kukk, Holger Gerhardt, Tatiana V. Petrova, David T. Shima and Andrea Lundkvist and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Michael Jeltsch

71 papers receiving 12.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

2003 2.1k citations Holger Gerhardt, Matt Golding et al. The Journal of Cell Biology profile →
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

2003 1.1k citations Tatiana V. Petrova, Michael Jeltsch et al. profile →
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice

1997 1.0k citations Michael Jeltsch, Vladimir Joukov et al. profile →
Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

1998 956 citations Marc G. Achen, Michael Jeltsch et al. profile →
Proteolytic processing regulates receptor specificity and activity of VEGF-C

1997 628 citations Vladimir Joukov, Vijay Kumar et al. The EMBO Journal profile →
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

2001 518 citations Terhi Kärpänen, Michael Jeltsch et al. The EMBO Journal profile →
VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development

1996 505 citations Michael Jeltsch, Vladimir Joukov et al. profile →

Peers

Countries citing papers authored by Michael Jeltsch

Since Specialization

Citations

This map shows the geographic impact of Michael Jeltsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Jeltsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Jeltsch more than expected).

Fields of papers citing papers by Michael Jeltsch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Jeltsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Jeltsch. The network helps show where Michael Jeltsch may publish in the future.

Co-authorship network of co-authors of Michael Jeltsch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Jeltsch. A scholar is included among the top collaborators of Michael Jeltsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Jeltsch. Michael Jeltsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biomass-derived lignin nanoparticles for the sustained delivery of vascular endothelial growth factor-C 2025 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Emanuela Gatto, (unknown), (unknown), (unknown), Cadia D’Ottavi, Elisabetta Di Bartolomeo, Fabio Domenici, (unknown), Alexandra Correia, (unknown), (unknown), Zahra Gounani, Timo Laaksonen, (unknown), Michael Jeltsch	1
2	Targeting bacterial and human levodopa decarboxylases for improved drug treatment of Parkinson's disease: Discovery and characterization of new inhibitors 2025 ·European Journal of Pharmaceutical Sciences ·(unknown), Léo Ghemtio, Jayvadan K. Patel, (unknown), (unknown), Jari Yli‐Kauhaluoma, Michael Jeltsch, Henri Xhaard, Petteri Piepponen, Päivi Tammela	3
3	Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase 2024 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Michael Jeltsch, Artturi Koivuniemi	1
4	The relationship between the secondary vascular system and the lymphatic vascular system in fish 2024 ·Biological reviews/Biological reviews of the Cambridge Philosophical Society ·(unknown), (unknown), Jörg Wilting, Katarzyna Koltowska, Michael Jeltsch	2
5	Expansion and collapse of VEGF diversity in major clades of the animal kingdom 2023 ·Angiogenesis ·(unknown), (unknown), Michael Jeltsch	8
6	VEGF-C protects the integrity of the bone marrow perivascular niche in mice 2020 ·Blood ·Shentong Fang, Shuo Chen, Harri Nurmi, Veli‐Matti Leppänen, Michael Jeltsch, David T. Scadden, Lev Silberstein, Hanna Mikkola, Kari Alitalo	44
7	Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1 2017 ·Scientific Reports ·Sawan Kumar Jha, (unknown), Terhi Kärpänen, Veli‐Matti Leppänen, Pascal Brouillard, Miikka Vikkula, Kari Alitalo, Michael Jeltsch	66
8	Lymphatic Vessels in Regenerative Medicine and Tissue Engineering 2016 ·Tissue Engineering Part B Reviews ·(unknown), Michael Jeltsch, Sabrina Rohringer, Heinz Redl, Wolfgang Holnthoner	34
9	Factors regulating the substrate specificity of cytosolic phospholipase A 2 -alpha in vitro 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·Krishna Chaithanya Batchu, (unknown), Sawan Kumar Jha, Michael Jeltsch, Pentti Somerharju	12
10	Ischemia–Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts 2015 ·American Journal of Transplantation ·(unknown), Alireza Raissadati, S. Syrjälä, Georgia Zarkada, Mikko Keränen, Raimo Tuuminen, R. Krebs, Andrey Anisimov, Michael Jeltsch, Veli‐Matti Leppänen, Kari Alitalo, Antti I. Nykänen, Karl Lemström	37
11	CCBE1 Enhances Lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3–Mediated Vascular Endothelial Growth Factor-C Activation 2014 ·Circulation ·Michael Jeltsch, Sawan Kumar Jha, Denis Tvorogov, Andrey Anisimov, Veli‐Matti Leppänen, Tanja Holopainen, Riikka Kivelä, Sagrario Ortega, Terhi Kärpänen, Kari Alitalo	178
12	Receptor Tyrosine Kinase-Mediated Angiogenesis 2013 ·Cold Spring Harbor Perspectives in Biology ·Michael Jeltsch, Veli‐Matti Leppänen, Pipsa Saharinen, Kari Alitalo	126
13	Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization 2010 ·Cancer Cell ·Denis Tvorogov, Andrey Anisimov, Wei Zheng, Veli‐Matti Leppänen, Tuomas Tammela, Simonas Laurinavičius, Wolfgang Holnthoner, Hanna Heloterä, Tanja Holopainen, Michael Jeltsch, Nisse Kalkkinen, Hilkka Lankinen, Päivi M. Ojala, Kari Alitalo	99
14	Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development 2010 ·Genes & Development ·Pipsa Saharinen, Hanna Heloterä, Juho J. Miettinen, Camilla Norrmén, Gabriela D’Amico, Michael Jeltsch, Tobias Langenberg, (unknown), Annelii Ny, Mieke Dewerchin, Peter Carmeliet, Kari Alitalo	31
15	Inhibition of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171 2007 ·Cancer Research ·Caroline A. Heckman, Tanja Holopainen, Maria Wirzenius, Salla Keskitalo, Michael Jeltsch, Stephen R. Wedge, Juliane M. Jürgensmeier	1
16	Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation 2005 ·Journal of Clinical Investigation ·Peter Bałuk, Tuomas Tammela, (unknown), Natalya Lyubynska, Marc G. Achen, Daniel J. Hicklin, Michael Jeltsch, Tatiana V. Petrova, Bronislaw Pytowski, Steven A. Stacker, Seppo Ylä‐Herttuala, David G. Jackson, Kari Alitalo, Donald M. McDonald	470
17	Dual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis 2005 ·American Journal of Respiratory and Critical Care Medicine ·R. Krebs, Jussi Tikkanen, Antti I. Nykänen, Jeanette M. Wood, Michael Jeltsch, Seppo Ylä‐Herttuala, Petri Koskinen, Karl Lemström	37
18	VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia breakdown → 2003 ·The Journal of Cell Biology ·Holger Gerhardt, Matt Golding, Marcus Fruttiger, Christiana Ruhrberg, Andrea Lundkvist, Alexandra Abramsson, Michael Jeltsch, Christopher A. Mitchell, Kari Alitalo, David T. Shima, Christer Betsholtz	2147
19	Genesis and pathogenesis of lymphatic vessels 2003 ·Cell and Tissue Research ·Michael Jeltsch, Tuomas Tammela, Kari Alitalo, J�rg Wilting	69
20	Proteolytic processing regulates receptor specificity and activity of VEGF-C breakdown → 1997 ·The EMBO Journal ·Vladimir Joukov, (unknown), Vijay Kumar, Michael Jeltsch, Lena Claesson‐Welsh, Yihai Cao, Olli Saksela, Nisse Kalkkinen, Kari Alitalo	628

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact